{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10968813", "DateCompleted": {"Year": "2000", "Month": "10", "Day": "02"}, "DateRevised": {"Year": "2019", "Month": "05", "Day": "01"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0959-8138", "JournalIssue": {"Volume": "321", "Issue": "7260", "PubDate": {"Year": "2000", "Month": "Sep", "Day": "02"}}, "Title": "BMJ (Clinical research ed.)", "ISOAbbreviation": "BMJ"}, "ArticleTitle": "Comparison of St John's wort and imipramine for treating depression: randomised controlled trial.", "Pagination": {"StartPage": "536", "EndPage": "539", "MedlinePgn": "536-9"}, "Abstract": {"AbstractText": ["To compare the efficacy and tolerability of Hypericum perforatum (St John's wort extract) with imipramine in patients with mild to moderate depression.", "Randomised, multicentre, double blind, parallel group trial.", "40 outpatient clinics in Germany.", "324 outpatients with mild to moderate depression.", "75 mg imipramine twice daily or 250 mg hypericum extract ZE 117 twice daily for 6 weeks.", "Hamilton depression rating scale, clinical global impression scale, and patient's global impression scale.", "Among the 157 participants taking hypericum mean scores on the Hamilton depression scale decreased from 22.4 at baseline to 12.00 at end point; among the 167 participants taking imipramine they fell from 22.1 to 12.75. Mean clinical global impression scores at end point were 2.22 out of 7 for the hypericum group and 2.42 for the imipramine group. On the 7 point self assessments of global improvement completed by participants (score of 1 indicating \"very much improved\" and 7 indicating \"very much deteriorated\") mean scores were 2.44 in the hypericum group and 2.60 in the imipramine group. None of the differences between treatment groups were significant. However, the mean score on the anxiety-somatisation subscale of the Hamilton scale (3.79 in the hypericum group and 4.26 in the imipramine group) indicated a significant advantage for hypericum relative to imipramine. Mean scores on the 5 point scale used by participants to assess tolerability (score of 1 indicating excellent tolerability and 5 indicating very poor tolerability) were better for hypericum (1.67) than imipramine (2.35). Adverse events occurred in 62/157 (39%) participants taking hypericum and in 105/167 (63%) taking imipramine. 4 (3%) participants taking hypericum withdrew because of adverse events compared with 26 (16%) taking imipramine.", "This Hypericum perforatum extract is therapeutically equivalent to imipramine in treating mild to moderate depression, but patients tolerate hypericum better."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Klinik f\u00fcr Psychiatrie und Psychotherapie, Akademisches Lehrkrankenhaus der Universit\u00e4t Giessen, Licher Strasse 106, D-35394 Giessen, Germany."}], "Identifier": [], "LastName": "Woelk", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Clinical Trial", "Comparative Study", "Journal Article", "Multicenter Study", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMJ", "NlmUniqueID": "8900488", "ISSNLinking": "0959-8138"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents, Tricyclic"}, {"RegistryNumber": "OGG85SX4E4", "NameOfSubstance": "Imipramine"}], "CommentsCorrectionsList": [{"RefSource": "BMJ. 2001 Feb 24;322(7284):493; author reply 494.", "PMID": "11222430"}, {"RefSource": "BMJ. 2001 Feb 24;322(7284):493; author reply 494.", "PMID": "11222432"}, {"RefSource": "BMJ. 2001 Feb 24;322(7284):493; author reply 494.", "PMID": "11222434"}, {"RefSource": "BMJ. 2001 Feb 24;322(7284):493-4.", "PMID": "11256367"}, {"RefSource": "BMJ. 2001 Sep 8;323(7312):574. doi: 10.1136/bmj.323.7312.574", "PMID": "11573492"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antidepressive Agents, Tricyclic"}, {"QualifierName": ["drug therapy", "psychology"], "DescriptorName": "Depression"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Hypericum"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Imipramine"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Psychiatric Status Rating Scales"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Fernie WT. Herbal simples. Bristol: John Wright; 1897."}, {"Citation": "Pratt A. Wild flowers. London: Society for Promoting Christian Knowledge; 1853."}, {"Citation": "Pickering C. Chronological history of plants. Boston: Little Brown; 1879."}, {"Citation": "Commission Nationale de Pharmacop\u00e9e France. Pharmacop\u00e9e fran\u00e7aise. 10th ed. Paris: Adrapharm; 1982."}, {"Citation": "Kommission Deutscher Arzneimittel-Codex. Johanniskraut\u2014Hyperici herba. DAC; 1986."}, {"Citation": "Linde K, Ramirez G, Mulrow C D, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression\u2014an overview and meta-analysis of randomised clinical trials. BMJ. 1996;313:253\u2013258.", "ArticleIdList": ["PMC2351679", "8704532"]}, {"Citation": "Wheatley D. LI160, an extract of St John's wort versus amitriptyline in mildly to moderately depressed outpatients\u2014a controlled 6-week clinical trial. Pharmacopsychiatry. 1997;30(suppl):77\u201380.", "ArticleIdList": ["9342764"]}, {"Citation": "Vorbach EU, H\u00fcbner WD, Arnoldt KH. Effectiveness and tolerance of the hypericum extract LI160 in comparison with imipramine: randomised double-blind study in 135 outpatients. J Geriat Psychiatry Neurol. 1994;7(suppl 1):19\u201323S.", "ArticleIdList": ["7857502"]}, {"Citation": "H\u00e4nsgen KD, Vesper J, Ploch M. Multicentre double-blind study examining the antidepressant effectiveness of the hypericum extract LI160. J Geriat Psychiatry Neurol. 1994;7(suppl 1):15\u20138S.", "ArticleIdList": ["7857501"]}, {"Citation": "Witte B, Harrer G, Kaplan T, Podzuweit H, Schmidt U. Treatment of depression with a highly concentrated hypericum preparation: a multicentre, placebo-controlled, double-blind study. Fortschr Med. 1995;113:404\u2013408.", "ArticleIdList": ["7498868"]}, {"Citation": "Schrader E, Meier B, Brattstr\u00f6m A. Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study. Hum Psychopharmacol. 1998;13:163\u2013169."}, {"Citation": "Harrer G, H\u00fcbner WD, Podzuweit H. Effectiveness and tolerance of the hypericum extract LI160 compared with maprotiline: a multicentre double-blind study. J Geriat Psychiatry Neurol. 1994;7(suppl 1):24\u20138S.", "ArticleIdList": ["7857503"]}, {"Citation": "Vorbach EU, Arnoldt KH, H\u00fcbner WD. Efficacy and tolerability of St John's wort extract LI160 versus imipramine in patients with severe depressive episodes according to ICD10. Pharmacopsychiatry. 1997;30(suppl):81\u201385.", "ArticleIdList": ["9342765"]}, {"Citation": "Ernst E. St John's wort as antidepressive therapy. Fortschr Med. 1995;113:354\u2013355.", "ArticleIdList": ["7498848"]}, {"Citation": "Angst J, Bech P, Boyer P, Bruinvels J, Engel R, Helmchen H. Consensus on the methodology of clinical trials of antidepressants, Zurich, March 1988: report of the Consensus Committee. Pharmacopsychiatry. 1989;22:3\u20137."}, {"Citation": "International Conference on Harmonisation, Committee on Proprietary Medicinal Products. Notes for guidance on good clinical practice. London: European Agency for Evaluation of Medicinal Products; 1997. . (ICH/135/95.)"}, {"Citation": "European Union. Good clinical practice for clinical investigation of medicines in the European Community. Vol. 3. London: European Agency for Evaluation of Medicinal Products; 1996. pp. 115\u2013132."}, {"Citation": "Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.", "ArticleIdList": ["PMC495331", "14399272"]}, {"Citation": "Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278\u2013296.", "ArticleIdList": ["6080235"]}, {"Citation": "National Institute of Mental Health. 028 CGI clinical global impressions. In: Guy W, editor. ECD-EU assessment for psychopharmacology. Rev ed. Rockville, MD: National Institute of Mental Health; 1976. pp. 217\u2013222."}, {"Citation": "Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ. 1996;313:36\u201339.", "ArticleIdList": ["PMC2351444", "8664772"]}, {"Citation": "DeSmet PA, Molen WA. St John's wort as an antidepressant. BMJ. 1996;313:241\u2013242.", "ArticleIdList": ["PMC2351659", "8704522"]}, {"Citation": "Philipp M, Kohnen R, Hiller KO. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks. BMJ. 1999;319:1534\u20131538.", "ArticleIdList": ["PMC28296", "10591711"]}, {"Citation": "Ruschitzka F, Meier PJ, Turina M, Luescher TF, Noll G. Acute heart transplant rejection due to St John's wort. Lancet. 2000;355:548\u2013549.", "ArticleIdList": ["10683008"]}, {"Citation": "Johne A, Brockm\u00f6ller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum) Clin Pharmacol Ther. 1999;66:338\u2013345.", "ArticleIdList": ["10546917"]}, {"Citation": "Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John's wort. Lancet. 2000;355:547\u2013548.", "ArticleIdList": ["10683007"]}, {"Citation": "Nebel A, Schneider BJ, Baker RK, Kroll DJ. Potential metabolic interaction between St. John's wort and theophylline. Ann Pharmacother. 1999;33:502.", "ArticleIdList": ["10332544"]}]}], "History": [{"Year": "2000", "Month": "9", "Day": "1", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "10", "Day": "7", "Hour": "11", "Minute": "1"}, {"Year": "2000", "Month": "9", "Day": "1", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "9", "Day": "2"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10968813", "PMC27467", "10.1136/bmj.321.7260.536"]}}], "PubmedBookArticle": []}